Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: AIO-Studien-gGmbH
Woman and Man Max 99 years
AIO-Studien-gGmbH
Update Il y a 4 ans
Neoadjuvant plus adjuvant or only adjuvant nab-Paclitaxel plus Gemcitabine for resectable pancreatic cancer - The AIO-NEONAX trial (AIO-PAK-0313) A prospective, randomized, controlled, phase II study of the AIO Pancreatic Cancer Group Neoadjuvante plus adjuvante Gabe oder alleinige adjuvante Gabe von Nab-Paclitaxel in Kombination mit Gemcitabine bei Patienten mit resektablem Pankreaskarzinom
Disease free survival (DFS) rate assessed by imaging 18 months after randomization (improvement of DFS rate at 18 months in both arms to ≥ 55%) krankheitsfreie Überlebensrate (DFS) 18 Monate na...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
AIO-Studien-gGmbH
Update Il y a 4 ans
The role of Rivaroxaban in the treatment of tumor patients with thrombosis Rivaroxaban in der Behandlung von Tumorpatienten mit Thrombosen
Patient-reported treatment satisfaction (convenience) with Rivaroxaban in the treatment of acute VTE in cancer patients in comparison with the standard treatment with low molecular weight heparin (LMW...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2
3
4